Refract IP — Patent consulting for life sciences companies and investors
Practice
Refract IP advises pharmaceutical companies, biotechnology companies, and investors on competitive patent landscapes and IP strategy. The firm's focus is life sciences — Hatch-Waxman and paragraph IV dynamics, Orange Book strategy, patent cliff analysis, and AI-related legal questions at the science-business intersection.
The firm has a particular interest in artificial intelligence and its implications for legal services — including how AI is reshaping IP practice, legal research, and the delivery of legal work across the life sciences industry.
Latest
- Agentic AI for Lawyers: How It Works
A practical, non-technical primer on how modern AI actually works: the vocabulary, what happens to information you put into it, and a side-by-side comparison of how a lawyer can reach these tools.